SCHEMBL24865653

SCHEMBL24865653

FC(F)(F)C1CCN(c2ccc(Nc3ccc4occc4c3)cc2)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.37
CHRNA7 P36544 4/20 0.35
HTR3A P46098 4/20 0.35
HTR3E A5X5Y0 1/20 0.35
HTR3B O95264 1/20 0.35
CYP2D6 P10635 1/20 0.35
HTR3D Q70Z44 1/20 0.35
HTR3C Q8WXA8 1/20 0.35
EPM2A O95278 1/20 0.35
PTPRC P08575 1/20 0.35
PTPN6 P29350 1/20 0.35
CDC14A Q9UNH5 1/20 0.35
PTPN22 Q9Y2R2 1/20 0.35
PHGDH O43175 1/20 0.34
CHRM1 P11229 1/20 0.34
MAPT P10636 3/20 0.34
MAPK1 P28482 2/20 0.34
TP53 P04637 1/20 0.34
CHRNB2 P17787 1/20 0.34
CHRNA4 P43681 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24865672 0.91 CNR2 (0.37) CNR2CHRNA7HTR3AHTR3EHTR3B
SCHEMBL30336647 0.91 CNR2 (0.37) CNR2CHRNA7HTR3AHTR3EHTR3B
SCHEMBL24864995 0.83 ACHE (0.46) CNR2MAPTKDM4EMEN1ALDH1A1
SCHEMBL24865700 0.79 ULK1 (0.37) CNR2MAPTMAPK1TP53NR4A1
SCHEMBL30336302 0.79 ULK1 (0.37) CNR2MAPTMAPK1TP53NR4A1
SCHEMBL24865093 0.77 MAPT (0.36) CNR2MAPTMAPK1TP53NR4A1
SCHEMBL24865763 0.77 ULK1 (0.46) CNR2MAPTMAPK1NR4A1TSHR
SCHEMBL24865755 0.75 EGFR (0.40) CNR2CHRNA7MAPTMAPK1NR4A1
SCHEMBL28882967 0.75 MAPT (0.38) CNR2MAPTMAPK1TP53NR4A1
SCHEMBL24865673 0.75 JAK1 (0.41) CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240327393-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2024-10-03 US disclosed
CN-117999259-A Iron death modulators, their preparation and use 维泰瑞隆有限公司 2024-05-07 CN disclosed
WO-2023280296-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-01-12 WO disclosed
WO-2023280296-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240327393-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF AIFM2, GPX1, GPX4 CNR2 3115/4885CHRNA7 4858/4885HTR3A 4363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.